CN101962651B - 一种来自深海宏基因组的l-蛋氨酸裂解酶基因及其表达产物 - Google Patents
一种来自深海宏基因组的l-蛋氨酸裂解酶基因及其表达产物 Download PDFInfo
- Publication number
- CN101962651B CN101962651B CN2010101090280A CN201010109028A CN101962651B CN 101962651 B CN101962651 B CN 101962651B CN 2010101090280 A CN2010101090280 A CN 2010101090280A CN 201010109028 A CN201010109028 A CN 201010109028A CN 101962651 B CN101962651 B CN 101962651B
- Authority
- CN
- China
- Prior art keywords
- methionine
- met
- gene
- lyase
- ala
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108010043135 L-methionine gamma-lyase Proteins 0.000 title abstract description 37
- 230000014509 gene expression Effects 0.000 title abstract description 20
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 68
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 25
- 238000000034 method Methods 0.000 claims abstract description 16
- 241000588724 Escherichia coli Species 0.000 claims abstract description 15
- 150000001413 amino acids Chemical class 0.000 claims abstract description 11
- 229960004452 methionine Drugs 0.000 claims description 79
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 77
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 claims description 68
- 229930195722 L-methionine Natural products 0.000 claims description 68
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical group CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 claims description 25
- 108090000856 Lyases Proteins 0.000 claims description 19
- 230000008521 reorganization Effects 0.000 claims description 18
- 230000001939 inductive effect Effects 0.000 claims description 15
- 230000006698 induction Effects 0.000 claims description 14
- 102000004317 Lyases Human genes 0.000 claims description 11
- 238000006555 catalytic reaction Methods 0.000 claims description 10
- 229930182817 methionine Natural products 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 9
- 239000013604 expression vector Substances 0.000 claims description 7
- 125000003729 nucleotide group Chemical group 0.000 claims description 7
- 206010028980 Neoplasm Diseases 0.000 claims description 6
- 230000001580 bacterial effect Effects 0.000 claims description 6
- 239000002773 nucleotide Substances 0.000 claims description 6
- 238000003259 recombinant expression Methods 0.000 claims description 6
- 201000011510 cancer Diseases 0.000 claims description 5
- 239000003153 chemical reaction reagent Substances 0.000 claims description 5
- 238000012360 testing method Methods 0.000 claims description 5
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 claims description 4
- 238000001514 detection method Methods 0.000 claims description 4
- QWCKQJZIFLGMSD-UHFFFAOYSA-N alpha-aminobutyric acid Chemical compound CCC(N)C(O)=O QWCKQJZIFLGMSD-UHFFFAOYSA-N 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 239000000796 flavoring agent Substances 0.000 claims description 3
- 235000019634 flavors Nutrition 0.000 claims description 3
- 235000013305 food Nutrition 0.000 claims description 3
- 230000002101 lytic effect Effects 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 12
- 102000004190 Enzymes Human genes 0.000 description 65
- 108090000790 Enzymes Proteins 0.000 description 65
- 210000004027 cell Anatomy 0.000 description 25
- 239000000243 solution Substances 0.000 description 24
- 239000006228 supernatant Substances 0.000 description 24
- 239000007788 liquid Substances 0.000 description 22
- 101150017331 mgl gene Proteins 0.000 description 20
- 239000000047 product Substances 0.000 description 19
- 235000018102 proteins Nutrition 0.000 description 19
- 238000006243 chemical reaction Methods 0.000 description 17
- 238000013016 damping Methods 0.000 description 15
- 239000012530 fluid Substances 0.000 description 15
- 241000894006 Bacteria Species 0.000 description 14
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 14
- 238000004458 analytical method Methods 0.000 description 13
- 108020004414 DNA Proteins 0.000 description 12
- 239000002253 acid Substances 0.000 description 12
- 239000012634 fragment Substances 0.000 description 12
- 230000008021 deposition Effects 0.000 description 11
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 10
- 239000013612 plasmid Substances 0.000 description 10
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 9
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 8
- 241000948243 Idiomarina Species 0.000 description 7
- 241000795139 Idiomarina loihiensis L2TR Species 0.000 description 7
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 7
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 5
- 239000012139 lysis buffer Substances 0.000 description 5
- 102220023258 rs387907548 Human genes 0.000 description 5
- 239000013049 sediment Substances 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 238000002525 ultrasonication Methods 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 102100022087 Granzyme M Human genes 0.000 description 4
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 4
- 241000589776 Pseudomonas putida Species 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 241000224527 Trichomonas vaginalis Species 0.000 description 4
- 239000003085 diluting agent Substances 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 230000004927 fusion Effects 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 238000005457 optimization Methods 0.000 description 4
- 238000003825 pressing Methods 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 3
- 229920002684 Sepharose Polymers 0.000 description 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 3
- 229940098773 bovine serum albumin Drugs 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 230000000875 corresponding effect Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000006911 enzymatic reaction Methods 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 210000003000 inclusion body Anatomy 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 229940049547 paraxin Drugs 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 239000001632 sodium acetate Substances 0.000 description 3
- 235000017281 sodium acetate Nutrition 0.000 description 3
- 102100029727 Enteropeptidase Human genes 0.000 description 2
- 108010013369 Enteropeptidase Proteins 0.000 description 2
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 2
- 241001272861 Idiomarina baltica OS145 Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 102000006833 Multifunctional Enzymes Human genes 0.000 description 2
- 108010047290 Multifunctional Enzymes Proteins 0.000 description 2
- 241000589516 Pseudomonas Species 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical class C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 2
- 230000037354 amino acid metabolism Effects 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 102220369447 c.1352G>A Human genes 0.000 description 2
- 102220369445 c.668T>C Human genes 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 238000005336 cracking Methods 0.000 description 2
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000013467 fragmentation Methods 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000009465 prokaryotic expression Effects 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 102220023257 rs387907546 Human genes 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
- 238000002798 spectrophotometry method Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000009182 swimming Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- FDKWRPBBCBCIGA-REOHCLBHSA-N (2r)-2-azaniumyl-3-$l^{1}-selanylpropanoate Chemical compound [Se]C[C@H](N)C(O)=O FDKWRPBBCBCIGA-REOHCLBHSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 101800000263 Acidic protein Proteins 0.000 description 1
- 241000607534 Aeromonas Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 244000177578 Bacterium linens Species 0.000 description 1
- 235000012539 Bacterium linens Nutrition 0.000 description 1
- 101710117545 C protein Proteins 0.000 description 1
- 241000936506 Citrobacter intermedius Species 0.000 description 1
- 241000193470 Clostridium sporogenes Species 0.000 description 1
- FDKWRPBBCBCIGA-UWTATZPHSA-N D-Selenocysteine Natural products [Se]C[C@@H](N)C(O)=O FDKWRPBBCBCIGA-UWTATZPHSA-N 0.000 description 1
- 241000224432 Entamoeba histolytica Species 0.000 description 1
- 108091029865 Exogenous DNA Proteins 0.000 description 1
- 241001407020 Idiomarina baltica Species 0.000 description 1
- 241000948245 Idiomarina loihiensis Species 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- FFFHZYDWPBMWHY-UHFFFAOYSA-N L-Homocysteine Natural products OC(=O)C(N)CCS FFFHZYDWPBMWHY-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- XUYPXLNMDZIRQH-LURJTMIESA-N N-acetyl-L-methionine Chemical compound CSCC[C@@H](C(O)=O)NC(C)=O XUYPXLNMDZIRQH-LURJTMIESA-N 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 241000605862 Porphyromonas gingivalis Species 0.000 description 1
- RJFAYQIBOAGBLC-BYPYZUCNSA-N Selenium-L-methionine Chemical compound C[Se]CC[C@H](N)C(O)=O RJFAYQIBOAGBLC-BYPYZUCNSA-N 0.000 description 1
- RJFAYQIBOAGBLC-UHFFFAOYSA-N Selenomethionine Natural products C[Se]CCC(N)C(O)=O RJFAYQIBOAGBLC-UHFFFAOYSA-N 0.000 description 1
- 101710137500 T7 RNA polymerase Proteins 0.000 description 1
- YVNQAIFQFWTPLQ-UHFFFAOYSA-O [4-[[4-(4-ethoxyanilino)phenyl]-[4-[ethyl-[(3-sulfophenyl)methyl]amino]-2-methylphenyl]methylidene]-3-methylcyclohexa-2,5-dien-1-ylidene]-ethyl-[(3-sulfophenyl)methyl]azanium Chemical compound C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C(=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S(O)(=O)=O)C)C=2C(=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S(O)(=O)=O)C)C=C1 YVNQAIFQFWTPLQ-UHFFFAOYSA-O 0.000 description 1
- BNSWSSGKYAJNRB-RGMNGODLSA-N [Se].C(CC)N[C@@H](CCO)C(=O)O Chemical compound [Se].C(CC)N[C@@H](CCO)C(=O)O BNSWSSGKYAJNRB-RGMNGODLSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000000516 activation analysis Methods 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000007068 beta-elimination reaction Methods 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 230000003570 biosynthesizing effect Effects 0.000 description 1
- 238000010504 bond cleavage reaction Methods 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 102220369446 c.1274G>A Human genes 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 229940007078 entamoeba histolytica Drugs 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- VRDKYJSLDJDLML-UHFFFAOYSA-N methylselenol Chemical compound [Se]C VRDKYJSLDJDLML-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000011275 oncology therapy Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000012803 optimization experiment Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 150000003233 pyrroles Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 102220023256 rs387907547 Human genes 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- ZKZBPNGNEQAJSX-UHFFFAOYSA-N selenocysteine Natural products [SeH]CC(N)C(O)=O ZKZBPNGNEQAJSX-UHFFFAOYSA-N 0.000 description 1
- 235000016491 selenocysteine Nutrition 0.000 description 1
- 229940055619 selenocysteine Drugs 0.000 description 1
- 229960002718 selenomethionine Drugs 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000012882 sequential analysis Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- SPOMEWBVWWDQBC-UHFFFAOYSA-K tripotassium;dihydrogen phosphate;hydrogen phosphate Chemical compound [K+].[K+].[K+].OP(O)([O-])=O.OP([O-])([O-])=O SPOMEWBVWWDQBC-UHFFFAOYSA-K 0.000 description 1
- 108010046845 tryptones Proteins 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101090280A CN101962651B (zh) | 2010-02-05 | 2010-02-05 | 一种来自深海宏基因组的l-蛋氨酸裂解酶基因及其表达产物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010101090280A CN101962651B (zh) | 2010-02-05 | 2010-02-05 | 一种来自深海宏基因组的l-蛋氨酸裂解酶基因及其表达产物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101962651A CN101962651A (zh) | 2011-02-02 |
CN101962651B true CN101962651B (zh) | 2012-06-13 |
Family
ID=43515704
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010101090280A Active CN101962651B (zh) | 2010-02-05 | 2010-02-05 | 一种来自深海宏基因组的l-蛋氨酸裂解酶基因及其表达产物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101962651B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105717309A (zh) * | 2016-04-07 | 2016-06-29 | 广州市微生物研究所 | 一种检测同型半胱氨酸的方法及试剂盒 |
CN114381468B (zh) * | 2021-12-30 | 2023-06-27 | 湖北工业大学 | 一种甲硫氨酸裂解酶及其编码基因和应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101534823A (zh) * | 2006-11-10 | 2009-09-16 | 宝洁公司 | 包含抗菌剂和宿主反应调节剂组合的口腔护理组合物 |
-
2010
- 2010-02-05 CN CN2010101090280A patent/CN101962651B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101534823A (zh) * | 2006-11-10 | 2009-09-16 | 宝洁公司 | 包含抗菌剂和宿主反应调节剂组合的口腔护理组合物 |
Non-Patent Citations (11)
Title |
---|
.L-蛋氨酸γ-裂解酶的研究进展.《生物技术通报》.2009,全文. |
于源华 |
唐晓莹 |
夏立亮 |
夏立亮;于源华;薛冉;王保学;.L-蛋氨酸γ-裂解酶的研究进展.《生物技术通报》.2009,全文. * |
时永辉.蛋氨酸裂解酶的基因克隆及序列分析.《医学研究生学报》.2006,第19卷(第12期),全文. |
王保学 |
薛冉 |
马百坤 |
马百坤;唐晓莹;黄惠臣;时永辉.蛋氨酸裂解酶的基因克隆及序列分析.《医学研究生学报》.2006,第19卷(第12期),全文. * |
黄惠臣 |
Also Published As
Publication number | Publication date |
---|---|
CN101962651A (zh) | 2011-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Huston et al. | Purification, characterization, and sequencing of an extracellular cold-active aminopeptidase produced by marine psychrophile Colwellia psychrerythraea strain 34H | |
De Graaf et al. | Inactivation of bacterial ribosome in vivo and in vitro by cloacin DF13 | |
Dudkina et al. | Three‐step procedure for preparation of pure Bacillus altitudinis ribonuclease | |
CN110358786B (zh) | 一种酶突变体 | |
CN101126097A (zh) | 一种吸水链霉菌的谷氨酰胺转胺酶酶原基因及其表达 | |
KR20160097691A (ko) | 신규 라이신 디카르복실라제 및 이를 이용하여 카다베린을 생산하는 방법 | |
CN111057694B (zh) | 一种来源于大额牛瘤胃的高活性纤维素酶及其基因 | |
CN101962651B (zh) | 一种来自深海宏基因组的l-蛋氨酸裂解酶基因及其表达产物 | |
Xu et al. | Identification of a novel class of photolyases as possible ancestors of their family | |
CN113462669B (zh) | 酮泛解酸羟甲基转移酶突变体、编码基因及其应用 | |
CN103468660A (zh) | 高活性中性植酸酶突变体及其基因和用途 | |
CN103352031B (zh) | 一种糖基转移酶基因及应用 | |
Li et al. | Global proteome response of Escherichia coli BL21 to production of human basic fibroblast growth factor in complex and defined medium | |
CN101165172B (zh) | 一种重组甲基营养杆菌及其应用 | |
KR100713104B1 (ko) | 뉴로스포라 크라사 유래의s-아데노실메티오닌-6-n-라이신-메틸트란스퍼라제, 그를코딩하는 폴리뉴클레오티드, 상기 폴리뉴클레오티드를포함하는 벡터 및 숙주세포 및 상기 숙주세포를 이용하여트리메틸라이신을 생산하는 방법 | |
CN105296513A (zh) | 一种海洋酯酶及其编码基因e22与应用 | |
CN102181468A (zh) | 酿酒酵母金属硫蛋白成熟肽的高效表达纯化方法 | |
CN112725315B (zh) | 一种壳聚糖酶及其突变体在制备壳寡糖中的应用 | |
CN104762306B (zh) | 一种海洋酯酶及其编码基因e32与应用 | |
CN103290039B (zh) | 一种来自动物粪便宏基因组的α-淀粉酶及其基因 | |
Cai et al. | Characterization of bacteriophage T3 DNA ligase | |
CN103667165A (zh) | 高产l-赖氨酸的生产菌株及其应用 | |
Xu et al. | High-level expression and single-step purification of human tryptophanyl-tRNA synthetase | |
CN109337887B (zh) | 一种Nucyep的编码基因、重组表达载体、重组工程菌及其制备方法和应用 | |
CN102649950B (zh) | 一种突变的中性植酸酶及其基因和用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: GUANGZHOU CITY INSTITUTE OF MICROBIOLOGY Free format text: FORMER OWNER: ZHONGSHAN UNIVERSITY Effective date: 20140312 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 510275 GUANGZHOU, GUANGDONG PROVINCE TO: 510663 GUANGZHOU, GUANGDONG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140312 Address after: 510663 Guangdong city of Guangzhou province Luogang District Science City Tower Road No. 1 Patentee after: GUANGDONG INSTITUTE OF MICROBIOLOGY Address before: 510275 Xingang West Road, Guangdong, Guangzhou, No. 135, No. Patentee before: Sun Yat-sen University |
|
CP03 | Change of name, title or address |
Address after: 510663 1 steeple Hill Road, Guangzhou, Guangdong, Luogang District Patentee after: Guangzhou Institute of Microbiology Co.,Ltd. Address before: 510663, spire mountain road, Luogang District Science Town, Guangdong, Guangzhou, 1 Patentee before: GUANGDONG INSTITUTE OF MICROBIOLOGY |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: No. 1, Jiantashan Road, Huangpu District, Guangzhou, Guangdong Province Patentee after: Guangzhou Institute of Microbiology Group Co.,Ltd. Address before: 510663 1 Pinnacle Road, Luogang District, Guangzhou, Guangdong Patentee before: Guangzhou Institute of Microbiology Co.,Ltd. |
|
CP03 | Change of name, title or address |